Publicacións en colaboración con investigadores/as de Clínica Universitaria de Navarra (3.831)

2025

  1. Prevalence of obesity and diabetes in Spain. Evolution in the last 10 years

    Atencion Primaria, Vol. 57, Núm. 3

2024

  1. #Pathart and cytopathology: Beauty must be shared

    Cytopathology, Vol. 35, Núm. 3, pp. 432-437

  2. 3-T MR-guided focused ultrasound thalamotomy for tremor in patients with a cardiac pacemaker: case series and review of the literature

    Neurosurgical Focus , Vol. 57, Núm. 3

  3. 68Ga-PSMA-11 PET/CT in Cherry Hemangiomas

    Clinical Nuclear Medicine, Vol. 49, Núm. 11, pp. e591-e592

  4. A Bioreactor for Celullarised Membrane Culture and Delivery under Sterile Conditions

    Bioengineering, Vol. 11, Núm. 8

  5. A Focus on the Pathophysiology of Adrenomedullin Expression: Endothelitis and Organ Damage in Severe Viral and Bacterial Infections

    Cells, Vol. 13, Núm. 11

  6. A New Suppression Index Calculation Using the Visually Enhanced Vestibulo-Ocular Reflex and Vestibulo-Ocular Reflex Suppression Paradigms in the Video Head Impulse Test

    Audiology Research, Vol. 14, Núm. 4, pp. 747-759

  7. A Pilot Study on Proteomic Predictors of Mortality in Stable COPD

    Cells, Vol. 13, Núm. 16

  8. A comprehensive examination of small-bowel capsule endoscopy in Spanish centers to meet European Society of Gastrointestinal Endoscopy standards

    Endoscopy International Open, Vol. 12, Núm. 3, pp. E344-E351

  9. A multidisciplinary team and patient perspective on omission of surgery after neoadjuvant systemic therapy for early breast cancer: A European Society of Surgical Oncology (ESSO) Research Academy survey

    European Journal of Surgical Oncology, Vol. 50, Núm. 10

  10. A new framework for the diagnosis, staging and management of obesity in adults

    Nature Medicine

  11. A new score for airway assessment using clinical and ultrasound parameters

    Frontiers in Medicine, Vol. 11

  12. A phase Ib study of the combination of naporafenib with rineterkib or trametinib in patients with advanced and metastatic KRAS- or BRAF-mutant non-small cell lung cancer

    Lung Cancer, Vol. 197

  13. A plain language summary of publication of the efficacy and safety of individualized niraparib dosing based on baseline body weight and platelet count in the PRIMA/ENGOT-OV26/GOG-3012 trial

    Future Oncology, Vol. 20, Núm. 13, pp. 799-809

  14. A plasma peptidomic signature reveals extracellular matrix remodeling and predicts prognosis in alcohol-associated hepatitis

    Hepatology Communications, Vol. 8, Núm. 8

  15. ASO Author Reflections: Confronting Challenges with Creativity: Innovating Minimally Invasive Pancreatic Surgery

    Annals of Surgical Oncology, Vol. 31, Núm. 7, pp. 4698-4699

  16. Abstracts of the 34th World Congress on Ultrasound in Obstetrics and Gynecology, 15-18 September 2024, Budapest, Hungary

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, Vol. 64, pp. 2

  17. Abstracts of the 34th World Congress on Ultrasound in Obstetrics and Gynecology, 15-18 September 2024, Budapest, Hungary

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, Vol. 64, pp. 10-11

  18. Access to melanoma drugs in Spain: a cross-sectional survey

    Clinical and Translational Oncology, Vol. 26, Núm. 10, pp. 2572-2583

  19. Access to systemic treatment of non-melanoma skin cancer in Spain: a survey analysis

    Clinical and Translational Oncology